Table 1. Percentages of YFP... | American Society of Hematology

Table 1.

Percentages of YFP⁺ bCMV/bLCV-specific CD4 T cells of total YFP⁺ CD4 T cells and, for comparison, percentages of YFP^- bCMV/bLCV-specific CD4 T cells of total YFP^- CD4 T cells

	bCMV-specific CD4 T cells, %			bLCV-specific CD4 T cells, %
Animal and time after transplantation, mo	YFP⁺	YFP^-	YFP⁺	YFP^-	YFP⁺	YFP^-
M00117
6	2.55	1.82	0.89	0.68	83	941
M00227
6	0.21	8.45	1.81	0.27	56	586
J00116
16	3.03	3.18	ND	ND	82	1618
M00093
3	0.75	0.02	ND	ND	137	532
5	0.34	1.05	1.19	0.43	143	334
6	0.47	2.84	1.56	0.75	192	578
15	1.01	2.11	0.29	0.34	659	1466

	bCMV-specific CD4 T cells, %			bLCV-specific CD4 T cells, %
Animal and time after transplantation, mo	YFP⁺	YFP^-	YFP⁺	YFP^-	YFP⁺	YFP^-
M00117
6	2.55	1.82	0.89	0.68	83	941
M00227
6	0.21	8.45	1.81	0.27	56	586
J00116
16	3.03	3.18	ND	ND	82	1618
M00093
3	0.75	0.02	ND	ND	137	532
5	0.34	1.05	1.19	0.43	143	334
6	0.47	2.84	1.56	0.75	192	578
15	1.01	2.11	0.29	0.34	659	1466

Percentages shown are averages of 2 independent experiments, except for EBV-specific cells in M00117, which were determined only once. Percentages were determined as percentage of IFN-γ⁺ YFP⁺ (YFP^-) CD3⁺CD4⁺ cells in the stimulated sample minus percentage of IFN-γ⁺ YFP⁺ (YFP^-) CD3⁺CD4⁺ cells in the negative control sample. ND indicates none detected.

View Large

This Feature Is Available To Subscribers Only